{
  "animalStudies": {
    "name": "Animal Studies",
    "categories": {
      "pharmacodynamics": {
        "name": "Pharmacodynamics",
        "subcategories": {
          "primary": {
            "name": "Primary Pharmacodynamics",
            "types": {
              "invivo": {
                "name": "In Vivo",
                "keywords": [
                  "In vivo Pharmacodynamics",
                  "Animal Models",
                  "Dose-Response Relationship, Drug",
                  "Drug Effects",
                  "Receptor Binding",
                  "Therapeutic Effect",
                  "Pharmacologic Action",
                  "Signal Transduction",
                  "Dynamic Drug Concentrations"
                ],
                "meshTerms": [
                  "In vivo Pharmacodynamics[MeSH]",
                  "Animal Models[MeSH]",
                  "Dose-Response Relationship, Drug[MeSH]",
                  "Drug Effects[MeSH]",
                  "Receptor Binding[MeSH]"
                ],
                "textKeywords": [
                  "Therapeutic Effect[tiab]",
                  "Pharmacologic Action[tiab]",
                  "Signal Transduction[tiab]",
                  "Dynamic Drug Concentrations[tiab]"
                ]
              },
              "invitro": {
                "name": "In Vitro",
                "keywords": [
                  "In vitro Pharmacodynamics",
                  "Cell Line, Tumor",
                  "Receptor Ligand Binding",
                  "Enzyme Inhibition",
                  "Binding Assay",
                  "Cell Culture Technique",
                  "In vitro Antimicrobial Activity"
                ],
                "meshTerms": [
                  "In vitro Pharmacodynamics[MeSH]",
                  "Cell Line, Tumor[MeSH]",
                  "Receptor Ligand Binding[MeSH]",
                  "Enzyme Inhibition[MeSH]",
                  "Cell Culture Technique[MeSH]",
                  "In vitro Antimicrobial Activity[MeSH]"
                ],
                "textKeywords": [
                  "Binding Assay[tiab]"
                ]
              }
            }
          },
          "secondary": {
            "name": "Secondary Pharmacodynamics",
            "types": {
              "general": {
                "name": "Secondary Pharmacological Actions",
                "keywords": [
                  "Secondary Pharmacological Actions",
                  "Off-Target Effects",
                  "Adverse Drug Reaction",
                  "Non-Specific Drug Effects",
                  "Side Effects",
                  "Downstream Signaling",
                  "Pharmacological Profiling"
                ],
                "meshTerms": [
                  "Adverse Drug Reaction[MeSH]"
                ],
                "textKeywords": [
                  "Secondary Pharmacological Actions[tiab]",
                  "Off-Target Effects[tiab]",
                  "Non-Specific Drug Effects[tiab]",
                  "Side Effects[tiab]",
                  "Downstream Signaling[tiab]",
                  "Pharmacological Profiling[tiab]"
                ]
              },
              "interaction": {
                "name": "Pharmacodynamic Drug Interaction",
                "keywords": [
                  "Pharmacodynamic Interaction",
                  "Drug Synergism",
                  "Drug Antagonism",
                  "Drug Interaction",
                  "Receptor Competition",
                  "Effect Modification",
                  "Therapeutic Drug Monitoring"
                ],
                "meshTerms": [
                  "Pharmacodynamic Interaction[MeSH]",
                  "Drug Synergism[MeSH]",
                  "Drug Antagonism[MeSH]",
                  "Drug Interaction[MeSH]",
                  "Therapeutic Drug Monitoring[MeSH]"
                ],
                "textKeywords": [
                  "Receptor Competition[tiab]",
                  "Effect Modification[tiab]"
                ]
              }
            }
          }
        }
      },
      "safetyPharmacology": {
        "name": "Safety Pharmacology",
        "subcategories": {
          "cns": {
            "name": "Effect on Central Nervous System (CNS)",
            "keywords": [
              "Central Nervous System",
              "Neurotoxicity",
              "Behavioral Toxicity",
              "Neuropharmacology",
              "Seizures",
              "Locomotor Activity",
              "Cognitive Dysfunction",
              "Neurotransmitter Release",
              "Motor Coordination"
            ],
            "meshTerms": [
              "Central Nervous System[MeSH]",
              "Neurotoxicity[MeSH]",
              "Behavioral Toxicity[MeSH]",
              "Neuropharmacology[MeSH]",
              "Seizures[MeSH]",
              "Locomotor Activity[MeSH]",
              "Cognitive Dysfunction[MeSH]"
            ],
            "textKeywords": [
              "Neurotransmitter Release[tiab]",
              "Motor Coordination[tiab]"
            ]
          },
          "cvs": {
            "name": "Effect on Cardiovascular System (CVS)",
            "keywords": [
              "Cardiovascular System",
              "Cardiotoxicity",
              "Electrocardiography",
              "QT Interval",
              "hERG Channel",
              "Arrhythmia",
              "Hemodynamics",
              "Blood Pressure",
              "Heart Rate"
            ],
            "meshTerms": [
              "Cardiovascular System[MeSH]",
              "Cardiotoxicity[MeSH]",
              "Electrocardiography[MeSH]",
              "QT Interval[MeSH]",
              "Arrhythmia[MeSH]",
              "Hemodynamics[MeSH]",
              "Blood Pressure[MeSH]",
              "Heart Rate[MeSH]"
            ],
            "textKeywords": [
              "hERG Channel[tiab]"
            ]
          },
          "other": {
            "name": "Other Effects",
            "keywords": [
              "Respiratory System",
              "Respiratory Function Tests",
              "Renal Toxicity",
              "Hepatotoxicity",
              "Gastrointestinal Toxicity",
              "Genotoxicity",
              "Immunotoxicity",
              "Toxicity Testing",
              "Animal Welfare"
            ],
            "meshTerms": [
              "Respiratory System[MeSH]",
              "Respiratory Function Tests[MeSH]",
              "Renal Toxicity[MeSH]",
              "Hepatotoxicity[MeSH]",
              "Gastrointestinal Toxicity[MeSH]",
              "Genotoxicity[MeSH]",
              "Immunotoxicity[MeSH]",
              "Toxicity Testing[MeSH]",
              "Animal Welfare[MeSH]"
            ],
            "textKeywords": []
          }
        }
      },
      "pharmacokinetics": {
        "name": "Pharmacokinetics",
        "keywords": [
          "Pharmacokinetic",
          "Pharmacokinetics",
          "Pharmaco-kinetic",
          "Pharma-cokinetic",
          "PK",
          "kinetic",
          "kinetics",
          "ADME"
        ],
        "meshTerms": [
          "Pharmacokinetics[MeSH]"
        ],
        "textKeywords": [
          "Pharmacokinetic[tiab]",
          "Pharmacokinetics[tiab]",
          "Pharmaco-kinetic[tiab]",
          "Pharma-cokinetic[tiab]",
          "PK[tiab]",
          "kinetic[tiab]",
          "kinetics[tiab]",
          "ADME[tiab]"
        ],
        "subcategories": {
          "methodOfAnalysis": {
            "name": "Method of Analysis",
            "keywords": [
              "Pharmacokinetic and HPLC",
              "Pharmacokinetic and High-performance liquid chromatography",
              "Pharmacokinetic and LC-MS",
              "Pharmacokinetic and LCMS",
              "Pharmacokinetic and Liquid chromatography-mass spectrometry",
              "Pharmacokinetic and Liquid chromatography mass spectrometry",
              "Bioanalytical Techniques",
              "Quantitative Assay"
            ],
            "meshTerms": [
              "Pharmacokinetics[MeSH]",
              "Bioanalytical Techniques[MeSH]",
              "Liquid Chromatography-Mass Spectrometry[MeSH]",
              "Chromatography, High Pressure Liquid[MeSH]"
            ],
            "textKeywords": [
              "HPLC[tiab]",
              "LC-MS[tiab]",
              "LCMS[tiab]",
              "High-performance liquid chromatography[tiab]",
              "Liquid chromatography-mass spectrometry[tiab]",
              "Bioanalytical Method[tiab]",
              "Analytical Method[tiab]"
            ]
          },
          "absorption": {
            "name": "Absorption",
            "keywords": [
              "Pharmacokinetic and bioavailability",
              "Pharmacokinetic and bio-availability",
              "Pharmacokinetic and absorption",
              "Pharmacokinetic and absorbed",
              "Pharmacokinetic and Cmax",
              "Pharmacokinetic and tmax",
              "Pharmacokinetic and AUC",
              "Pharmacokinetic and maximum drug concentration",
              "Pharmacokinetic and area under the curve",
              "Pharmacokinetic and area-under the curve",
              "Drug Absorption",
              "First-Pass Effect"
            ],
            "meshTerms": [
              "Biological Availability[MeSH]",
              "Intestinal Absorption[MeSH]",
              "Area Under Curve[MeSH]"
            ],
            "textKeywords": [
              "bioavailability[tiab]",
              "bio-availability[tiab]",
              "absorption[tiab]",
              "absorbed[tiab]",
              "Cmax[tiab]",
              "tmax[tiab]",
              "AUC[tiab]",
              "maximum drug concentration[tiab]",
              "area under the curve[tiab]",
              "area-under the curve[tiab]"
            ]
          },
          "distribution": {
            "name": "Distribution",
            "keywords": [
              "Pharmacokinetic and Volume of distribution",
              "Pharmacokinetic and distribution",
              "Pharmacokinetic and protein binding",
              "Pharmacokinetic and cytochrome",
              "Pharmacokinetic and Vd",
              "Tissue Distribution",
              "Blood-Brain Barrier"
            ],
            "meshTerms": [
              "Tissue Distribution[MeSH]",
              "Protein Binding[MeSH]",
              "Blood-Brain Barrier[MeSH]"
            ],
            "textKeywords": [
              "Volume of distribution[tiab]",
              "distribution[tiab]",
              "protein binding[tiab]",
              "cytochrome[tiab]",
              "Vd[tiab]"
            ]
          },
          "metabolism": {
            "name": "Metabolism",
            "keywords": [
              "Pharmacokinetic and metabolism",
              "Pharmacokinetic and metabolizm",
              "Pharmacokinetic and cytochrome",
              "Pharmacokinetic and metabolite",
              "Pharmacokinetic and biotransformation",
              "Pharmacokinetic and bio-transformation",
              "Pharmacokinetic and CYP",
              "Cytochrome P450 Enzymes",
              "Phase I Metabolism",
              "Phase II Metabolism"
            ],
            "meshTerms": [
              "Metabolic Clearance Rate[MeSH]",
              "Cytochrome P-450 Enzyme System[MeSH]",
              "Biotransformation[MeSH]"
            ],
            "textKeywords": [
              "metabolism[tiab]",
              "metabolizm[tiab]",
              "cytochrome[tiab]",
              "metabolite[tiab]",
              "biotransformation[tiab]",
              "bio-transformation[tiab]",
              "CYP[tiab]"
            ]
          },
          "excretion": {
            "name": "Excretion",
            "keywords": [
              "Pharmacokinetic and Excretion",
              "Pharmacokinetic and elimination",
              "Pharmacokinetic and clearance",
              "Pharmacokinetic and half life",
              "Pharmacokinetic and half-life",
              "Pharmacokinetic and t1/2",
              "Renal Clearance",
              "Biliary Excretion"
            ],
            "meshTerms": [
              "Kidney[MeSH]",
              "Metabolic Clearance Rate[MeSH]",
              "Half-Life[MeSH]"
            ],
            "textKeywords": [
              "Excretion[tiab]",
              "elimination[tiab]",
              "clearance[tiab]",
              "half life[tiab]",
              "half-life[tiab]",
              "t1/2[tiab]"
            ]
          },
          "specialPopulations": {
            "name": "Pharmacokinetics in Special Populations",
            "keywords": [
              "Pharmacokinetic in renal impairment",
              "Pharmacokinetic and kidney impairment",
              "Pharmacokinetic and renal impairment",
              "Pharmacokinetic and end stage renal disease",
              "Pharmacokinetic and renal disease",
              "Pharmacokinetic and kidney disease",
              "Pharmacokinetic and kidney dysfunction",
              "Pharmacokinetic and renal dysfunction",
              "Pharmacokinetic in hepatic impairment",
              "Pharmacokinetic and liver impairment",
              "Pharmacokinetic and hepatic impairment",
              "Pharmacokinetic and hepatic cirrhosis",
              "Pharmacokinetic and liver cirrhosis",
              "Pharmacokinetic and liver disease",
              "Pharmacokinetic and liver dysfunction",
              "Pharmacokinetic and hepatic dysfunction",
              "Pharmacokinetic and elderly",
              "Pharmacokinetic and paediatrics",
              "Pharmacokinetic and adolescent",
              "Pharmacokinetic and adolescents",
              "Pharmacokinetic and older",
              "Pharmacokinetic and pediatrics",
              "Pharmacokinetic and pediatric",
              "Pharmacokinetic and paediatric",
              "Pharmacokinetic and pregnancy",
              "Pharmacokinetic and race"
            ],
            "meshTerms": [
              "Renal Insufficiency[MeSH]",
              "Liver Cirrhosis[MeSH]",
              "Aged[MeSH]",
              "Child[MeSH]",
              "Adolescent[MeSH]",
              "Pregnancy[MeSH]"
            ],
            "textKeywords": [
              "renal impairment[tiab]",
              "kidney impairment[tiab]",
              "end stage renal disease[tiab]",
              "renal disease[tiab]",
              "kidney disease[tiab]",
              "kidney dysfunction[tiab]",
              "renal dysfunction[tiab]",
              "hepatic impairment[tiab]",
              "liver impairment[tiab]",
              "hepatic cirrhosis[tiab]",
              "liver cirrhosis[tiab]",
              "liver disease[tiab]",
              "liver dysfunction[tiab]",
              "hepatic dysfunction[tiab]",
              "elderly[tiab]",
              "paediatrics[tiab]",
              "adolescent[tiab]",
              "adolescents[tiab]",
              "pediatrics[tiab]",
              "pediatric[tiab]",
              "paediatric[tiab]",
              "pregnancy[tiab]",
              "race[tiab]",
              "gender[tiab]",
              "age[tiab]"
            ]
          },
          "drugInteraction": {
            "name": "Pharmacokinetics Drug Interaction",
            "keywords": [
              "Pharmacokinetic drug interaction",
              "Pharmacokinetic and interaction",
              "Pharmacokinetic and drug interaction",
              "Pharmacokinetic and population pharmacokinetics",
              "Pharmacokinetic and population pharmacokinetic"
            ],
            "meshTerms": [
              "Drug Interactions[MeSH]"
            ],
            "textKeywords": [
              "drug interaction[tiab]",
              "interaction[tiab]",
              "population pharmacokinetics[tiab]",
              "population pharmacokinetic[tiab]"
            ]
          },
          "other": {
            "name": "Other Pharmacokinetics Studies",
            "keywords": [
              "Pharmacokinetic Variability",
              "Dose Proportionality",
              "Pharmacokinetic Modeling",
              "Non-Compartmental Analysis",
              "Therapeutic Drug Monitoring"
            ],
            "meshTerms": [
              "Models, Biological[MeSH]",
              "Drug Monitoring[MeSH]"
            ],
            "textKeywords": [
              "Dose Proportionality[tiab]",
              "Pharmacokinetic Modeling[tiab]",
              "Non-Compartmental Analysis[tiab]",
              "population pharmacokinetics[tiab]"
            ]
          }
        }
      },
      "toxicology": {
        "name": "Toxicology",
        "subcategories": {
          "singleDose": {
            "name": "Single Dose Toxicity",
            "keywords": [
              "Acute Toxicity",
              "Single Dose Toxicity",
              "Dose Escalation",
              "Toxicological Evaluation"
            ],
            "meshTerms": [
              "Acute Toxicity[MeSH]"
            ],
            "textKeywords": [
              "Single Dose Toxicity[tiab]",
              "Dose Escalation[tiab]",
              "Toxicological Evaluation[tiab]"
            ]
          },
          "repeatDose": {
            "name": "Repeat Dose Toxicity",
            "keywords": [
              "Subchronic Toxicity",
              "Chronic Toxicity",
              "Repeat Dose Toxicity",
              "Toxicity Studies",
              "Dose-Response Relationship, Drug"
            ],
            "meshTerms": [
              "Subchronic Toxicity[MeSH]",
              "Chronic Toxicity[MeSH]",
              "Dose-Response Relationship, Drug[MeSH]"
            ],
            "textKeywords": [
              "Repeat Dose Toxicity[tiab]",
              "Toxicity Studies[tiab]"
            ]
          },
          "genotoxicity": {
            "name": "Genotoxicity",
            "keywords": [
              "Genotoxicity Tests",
              "Mutagenicity Tests",
              "DNA Damage",
              "Chromosome Aberrations",
              "Ames Test"
            ],
            "meshTerms": [
              "Genotoxicity Tests[MeSH]",
              "Mutagenicity Tests[MeSH]",
              "DNA Damage[MeSH]",
              "Chromosome Aberrations[MeSH]"
            ],
            "textKeywords": [
              "Ames Test[tiab]"
            ]
          },
          "carcinogenicity": {
            "name": "Carcinogenicity",
            "keywords": [
              "Carcinogenicity",
              "Neoplasms, Experimental",
              "Tumor Promotion",
              "Oncogenesis"
            ],
            "meshTerms": [
              "Carcinogenicity[MeSH]",
              "Neoplasms, Experimental[MeSH]",
              "Oncogenesis[MeSH]"
            ],
            "textKeywords": [
              "Tumor Promotion[tiab]"
            ]
          },
          "reproductiveToxicity": {
            "name": "Reproductive and Developmental Toxicity",
            "types": {
              "fertility": {
                "name": "Fertility and Early Embryonic Development",
                "keywords": [
                  "Fertility Regulation",
                  "Early Embryonic Development"
                ],
                "meshTerms": [
                  "Fertility Regulation[MeSH]"
                ],
                "textKeywords": [
                  "Early Embryonic Development[tiab]"
                ]
              },
              "embryoFetal": {
                "name": "Embryo Foetal Development",
                "keywords": [
                  "Embryo-Fetal Toxicity",
                  "Foetal Development"
                ],
                "meshTerms": [
                  "Foetal Development[MeSH]"
                ],
                "textKeywords": [
                  "Embryo-Fetal Toxicity[tiab]"
                ]
              },
              "prenatalPostnatal": {
                "name": "Prenatal and Postnatal Development",
                "keywords": [
                  "Prenatal Exposure Delayed Effects",
                  "Postnatal Development"
                ],
                "meshTerms": [
                  "Prenatal Exposure Delayed Effects[MeSH]"
                ],
                "textKeywords": [
                  "Postnatal Development[tiab]"
                ]
              }
            }
          },
          "localTolerance": {
            "name": "Local Tolerance",
            "keywords": [
              "Local Toxicity",
              "Irritation Tests",
              "Sensitization",
              "Dermal Toxicity"
            ],
            "meshTerms": [
              "Irritation Tests[MeSH]",
              "Sensitization[MeSH]",
              "Dermal Toxicity[MeSH]"
            ],
            "textKeywords": [
              "Local Toxicity[tiab]"
            ]
          },
          "otherToxicity": {
            "name": "Other Toxicity Studies",
            "keywords": [
              "Immunotoxicity",
              "Nephrotoxicity",
              "Hepatotoxicity",
              "Neurotoxicity",
              "Toxicokinetics",
              "Organ Toxicity"
            ],
            "meshTerms": [
              "Immunotoxicity[MeSH]",
              "Nephrotoxicity[MeSH]",
              "Hepatotoxicity[MeSH]",
              "Neurotoxicity[MeSH]",
              "Toxicokinetics[MeSH]"
            ],
            "textKeywords": [
              "Organ Toxicity[tiab]"
            ]
          }
        }
      }
    }
  },
  "humanStudies": {
    "name": "Human Studies",
    "categories": {
      "pharmacokinetics": {
        "name": "Pharmacokinetics",
        "subcategories": {
          "methodOfAnalysis": {
            "name": "Method of Analysis",
            "keywords": [
              "LC-MS/MS",
              "Liquid Chromatography-Mass Spectrometry",
              "Bioanalytical Method Validation",
              "Chromatography Techniques",
              "Quantitative Assay",
              "Sensitivity and Specificity",
              "Non-compartmental Analysis",
              "Compartmental Modeling",
              "Phoenix WinNonlin"
            ],
            "meshTerms": [
              "Liquid Chromatography-Mass Spectrometry[MeSH]",
              "Chromatography[MeSH]",
              "Sensitivity and Specificity[MeSH]"
            ],
            "textKeywords": [
              "LC-MS/MS[tiab]",
              "Bioanalytical Method Validation[tiab]",
              "Non-compartmental Analysis[tiab]",
              "Compartmental Modeling[tiab]",
              "Phoenix WinNonlin[tiab]"
            ]
          },
          "absorption": {
            "name": "Absorption",
            "keywords": [
              "Bioavailability",
              "First-pass Metabolism",
              "Gastric pH Influence",
              "Gastric Emptying Time",
              "Intestinal Transit Time",
              "Drug Solubility and Permeability",
              "P-glycoprotein",
              "Transporter Proteins",
              "Formulation Effects"
            ],
            "meshTerms": [
              "Biological Availability[MeSH]",
              "Gastrointestinal Transit[MeSH]",
              "ATP Binding Cassette Transporter, Subfamily B, Member 1[MeSH]",
              "Intestinal Absorption[MeSH]"
            ],
            "textKeywords": [
              "First-pass Metabolism[tiab]",
              "Gastric pH[tiab]",
              "P-glycoprotein[tiab]",
              "Formulation Effects[tiab]"
            ]
          },
          "distribution": {
            "name": "Distribution",
            "keywords": [
              "Volume of Distribution",
              "Plasma Protein Binding",
              "Tissue Penetration",
              "Blood-Brain Barrier",
              "Lipophilicity",
              "Tissue Binding",
              "Body Composition Effects"
            ],
            "meshTerms": [
              "Tissue Distribution[MeSH]",
              "Protein Binding[MeSH]",
              "Blood-Brain Barrier[MeSH]"
            ],
            "textKeywords": [
              "Volume of Distribution[tiab]",
              "Tissue Penetration[tiab]",
              "Lipophilicity[tiab]",
              "Body Composition[tiab]"
            ]
          },
          "metabolism": {
            "name": "Metabolism",
            "keywords": [
              "Hepatic Metabolism",
              "Cytochrome P450 Enzymes",
              "CYP450",
              "Phase I Metabolism",
              "Phase II Metabolism",
              "Enzyme Induction",
              "Enzyme Inhibition",
              "Metabolite Profiling",
              "Genetic Polymorphisms"
            ],
            "meshTerms": [
              "Cytochrome P-450 Enzyme System[MeSH]",
              "Metabolic Detoxication, Phase I[MeSH]",
              "Metabolic Detoxication, Phase II[MeSH]",
              "Enzyme Induction[MeSH]",
              "Polymorphism, Genetic[MeSH]"
            ],
            "textKeywords": [
              "Hepatic Metabolism[tiab]",
              "CYP450[tiab]",
              "Metabolite Profiling[tiab]"
            ]
          },
          "excretion": {
            "name": "Excretion",
            "keywords": [
              "Renal Clearance",
              "Biliary Excretion",
              "Glomerular Filtration Rate",
              "GFR",
              "Tubular Secretion",
              "Tubular Reabsorption",
              "Half-life",
              "Elimination Rate Constant"
            ],
            "meshTerms": [
              "Metabolic Clearance Rate[MeSH]",
              "Glomerular Filtration Rate[MeSH]",
              "Half-Life[MeSH]",
              "Kidney Tubules[MeSH]"
            ],
            "textKeywords": [
              "Renal Clearance[tiab]",
              "Biliary Excretion[tiab]",
              "Tubular Secretion[tiab]",
              "Elimination Rate[tiab]"
            ]
          },
          "specialPopulations": {
            "name": "Pharmacokinetics in Special Populations",
            "keywords": [
              "Pediatric Pharmacokinetics",
              "Geriatric Pharmacokinetics",
              "Pregnancy Pharmacokinetics",
              "Renal Impairment",
              "Hepatic Impairment",
              "Age-related Physiological Changes",
              "Polypharmacy Effects",
              "Dose Adjustment"
            ],
            "meshTerms": [
              "Aged[MeSH]",
              "Child[MeSH]",
              "Pregnancy[MeSH]",
              "Renal Insufficiency[MeSH]",
              "Liver Diseases[MeSH]",
              "Polypharmacy[MeSH]"
            ],
            "textKeywords": [
              "Pediatric Pharmacokinetics[tiab]",
              "Geriatric[tiab]",
              "Dose Adjustment[tiab]",
              "Special Populations[tiab]"
            ]
          },
          "drugInteraction": {
            "name": "Pharmacokinetics Drug Interaction",
            "keywords": [
              "Drug-Drug Interaction",
              "Enzyme Induction",
              "Enzyme Inhibition",
              "Transporter-Mediated Interaction",
              "Pharmacokinetic Interaction Mechanisms",
              "Clinical Significance of Interactions",
              "Therapeutic Drug Monitoring"
            ],
            "meshTerms": [
              "Drug Interactions[MeSH]",
              "Enzyme Induction[MeSH]",
              "Drug Monitoring[MeSH]"
            ],
            "textKeywords": [
              "Drug-Drug Interaction[tiab]",
              "Transporter-Mediated[tiab]",
              "Pharmacokinetic Interaction[tiab]"
            ]
          }
        }
      },
      "pharmacodynamics": {
        "name": "Pharmacodynamics",
        "subcategories": {
          "proposedIndications": {
            "name": "Related to Proposed Indications",
            "keywords": [
              "Dose-Response Relationship",
              "Receptor Binding",
              "Receptor Sensitivity",
              "Agonist",
              "Antagonist",
              "Efficacy",
              "Potency",
              "Therapeutic Index",
              "Mechanism of Action",
              "Target Tissue",
              "Post-Receptor Effects",
              "Signal Transduction",
              "Pharmacologic Effect",
              "Clinical Biomarkers",
              "Therapeutic Window",
              "Receptor Selectivity"
            ],
            "meshTerms": [
              "Dose-Response Relationship, Drug[MeSH]",
              "Receptors, Drug[MeSH]",
              "Drug Agonists[MeSH]",
              "Drug Antagonists[MeSH]",
              "Biomarkers[MeSH]"
            ],
            "textKeywords": [
              "Mechanism of Action[tiab]",
              "Therapeutic Index[tiab]",
              "Signal Transduction[tiab]",
              "Receptor Selectivity[tiab]",
              "Therapeutic Window[tiab]"
            ]
          },
          "drugInteraction": {
            "name": "Pharmacodynamic Drug Interaction",
            "keywords": [
              "Receptor Competition",
              "Synergistic Effect",
              "Antagonistic Effect",
              "Additive Effect",
              "Drug Interaction Mechanism",
              "Receptor Modulation",
              "Enzyme Inhibition",
              "Enzyme Induction",
              "Toxicodynamic Interaction",
              "Therapeutic Drug Monitoring",
              "Drug Resistance",
              "Altered Signal Transduction"
            ],
            "meshTerms": [
              "Drug Interactions[MeSH]",
              "Drug Synergism[MeSH]",
              "Drug Resistance[MeSH]",
              "Signal Transduction[MeSH]"
            ],
            "textKeywords": [
              "Receptor Competition[tiab]",
              "Synergistic Effect[tiab]",
              "Antagonistic Effect[tiab]",
              "Toxicodynamic[tiab]"
            ]
          }
        }
      },
      "efficacy": {
        "name": "Efficacy",
        "subcategories": {
          "placeboControlled": {
            "name": "Placebo-Controlled Studies",
            "keywords": [
              "Randomized Controlled Trial",
              "RCT",
              "Placebo Group",
              "Double-Blind",
              "Blinding",
              "Control Group",
              "Treatment Effect",
              "Statistical Significance",
              "Intention-to-Treat Analysis",
              "Relative Risk Reduction",
              "RRR",
              "Absolute Risk Reduction",
              "ARR",
              "Number Needed to Treat",
              "NNT"
            ],
            "meshTerms": [
              "Randomized Controlled Trial[Publication Type]",
              "Placebos[MeSH]",
              "Double-Blind Method[MeSH]",
              "Treatment Outcome[MeSH]"
            ],
            "textKeywords": [
              "Placebo-Controlled[tiab]",
              "Number Needed to Treat[tiab]",
              "Intention-to-Treat[tiab]"
            ]
          },
          "activeControlled": {
            "name": "Active-Controlled Studies",
            "keywords": [
              "Active Comparator",
              "Non-Inferiority Trial",
              "Equivalence Trial",
              "Head-to-Head Comparison",
              "Superiority Trial",
              "Dose Comparison",
              "Efficacy Endpoint",
              "Comparative Effectiveness",
              "Treatment Arms"
            ],
            "meshTerms": [
              "Comparative Effectiveness Research[MeSH]",
              "Equivalence Trial[Publication Type]"
            ],
            "textKeywords": [
              "Active Comparator[tiab]",
              "Non-Inferiority[tiab]",
              "Head-to-Head[tiab]",
              "Superiority Trial[tiab]"
            ]
          },
          "uncontrolled": {
            "name": "Uncontrolled Studies",
            "keywords": [
              "Open-Label Study",
              "Single-Arm Study",
              "Observational Study",
              "Case Series",
              "Pilot Study",
              "Exploratory Study",
              "Historical Controls"
            ],
            "meshTerms": [
              "Observational Study[Publication Type]",
              "Pilot Projects[MeSH]"
            ],
            "textKeywords": [
              "Open-Label[tiab]",
              "Single-Arm[tiab]",
              "Case Series[tiab]",
              "Historical Controls[tiab]"
            ]
          },
          "paediatrics": {
            "name": "Efficacy in Paediatrics",
            "keywords": [
              "Pediatric Population",
              "Paediatric",
              "Age Stratification",
              "Developmental Pharmacology",
              "Pediatric Dose Adjustment",
              "Growth and Maturation",
              "Pediatric Clinical Trials",
              "Safety and Efficacy in Children"
            ],
            "meshTerms": [
              "Child[MeSH]",
              "Pediatrics[MeSH]",
              "Adolescent[MeSH]",
              "Infant[MeSH]"
            ],
            "textKeywords": [
              "Pediatric[tiab]",
              "Paediatric[tiab]",
              "Children[tiab]",
              "Developmental Pharmacology[tiab]"
            ]
          },
          "dosage": {
            "name": "Dosage",
            "keywords": [
              "Dose-Response Relationship",
              "Therapeutic Dose",
              "Dose Escalation",
              "Maximum Tolerated Dose",
              "MTD",
              "Dose Optimization",
              "Dosing Regimen",
              "Steady-State Concentration",
              "Pharmacodynamics Correlation"
            ],
            "meshTerms": [
              "Dose-Response Relationship, Drug[MeSH]",
              "Maximum Tolerated Dose[MeSH]"
            ],
            "textKeywords": [
              "Dose Escalation[tiab]",
              "Dose Optimization[tiab]",
              "Dosing Regimen[tiab]",
              "Steady-State[tiab]"
            ]
          }
        }
      },
      "safety": {
        "name": "Safety",
        "subcategories": {
          "adverseReactions": {
            "name": "Adverse Drug Reactions (ADR)",
            "keywords": [
              "Adverse Event",
              "AE",
              "Serious Adverse Event",
              "SAE",
              "Side Effect",
              "Dose-Related Toxicity",
              "Hypersensitivity Reactions",
              "Idiosyncratic Reaction",
              "Causality Assessment",
              "Pharmacovigilance",
              "Risk Management",
              "Safety Signal Detection"
            ],
            "meshTerms": [
              "Adverse Drug Reaction Reporting Systems[MeSH]",
              "Drug-Related Side Effects and Adverse Reactions[MeSH]",
              "Pharmacovigilance[MeSH]"
            ],
            "textKeywords": [
              "Adverse Event[tiab]",
              "Side Effect[tiab]",
              "Safety Signal[tiab]",
              "Idiosyncratic[tiab]"
            ]
          },
          "warningsAndPrecautions": {
            "name": "Special Warnings and Precautions",
            "keywords": [
              "Contraindications",
              "Black Box Warning",
              "Risk Minimization Measures",
              "Monitoring Parameters",
              "Drug Safety Alerts",
              "Precautionary Statements",
              "Warning Labels",
              "Risk-Benefit Analysis"
            ],
            "meshTerms": [
              "Contraindications[MeSH]",
              "Risk Assessment[MeSH]"
            ],
            "textKeywords": [
              "Black Box Warning[tiab]",
              "Precautions[tiab]",
              "Risk-Benefit[tiab]",
              "Safety Alert[tiab]"
            ]
          },
          "pregnancy": {
            "name": "Pregnancy",
            "keywords": [
              "Teratogenicity",
              "Embryotoxicity",
              "Pregnancy Exposure Registry",
              "Fetal Risk",
              "Pregnancy and Lactation Labeling Rule",
              "PLLR",
              "Gestational Timing of Exposure",
              "Maternal-Fetal Drug Transfer",
              "Reproductive Toxicology"
            ],
            "meshTerms": [
              "Pregnancy[MeSH]",
              "Teratogens[MeSH]",
              "Abnormalities, Drug-Induced[MeSH]",
              "Maternal-Fetal Exchange[MeSH]"
            ],
            "textKeywords": [
              "Pregnancy[tiab]",
              "Teratogenicity[tiab]",
              "Fetal Risk[tiab]",
              "Gestational[tiab]"
            ]
          },
          "breastfeeding": {
            "name": "Breast-feeding",
            "keywords": [
              "Drug Transfer into Breast Milk",
              "Milk-to-Plasma Ratio",
              "Infant Exposure",
              "Lactation Risk Assessment",
              "Neonatal Toxicity",
              "Breastfeeding Safety"
            ],
            "meshTerms": [
              "Breast Feeding[MeSH]",
              "Milk, Human[MeSH]",
              "Lactation[MeSH]"
            ],
            "textKeywords": [
              "Breast Milk[tiab]",
              "Milk-to-Plasma[tiab]",
              "Lactation[tiab]",
              "Breastfeeding[tiab]"
            ]
          },
          "fertility": {
            "name": "Fertility",
            "keywords": [
              "Reproductive Toxicity",
              "Infertility Risk",
              "Gametotoxicity",
              "Fertility Studies"
            ],
            "meshTerms": [
              "Fertility[MeSH]",
              "Reproductive Toxicity[MeSH]",
              "Infertility[MeSH]"
            ],
            "textKeywords": [
              "Fertility[tiab]",
              "Gametotoxicity[tiab]",
              "Reproductive Function[tiab]"
            ]
          },
          "overdose": {
            "name": "Overdose",
            "keywords": [
              "Toxic Dose",
              "Poisoning",
              "Acute Toxicity",
              "Overdosage Management",
              "Antidote",
              "Supportive Care",
              "Dose-Limiting Toxicity"
            ],
            "meshTerms": [
              "Drug Overdose[MeSH]",
              "Poisoning[MeSH]",
              "Antidotes[MeSH]"
            ],
            "textKeywords": [
              "Overdose[tiab]",
              "Toxic Dose[tiab]",
              "Overdosage[tiab]"
            ]
          },
          "postMarketing": {
            "name": "Post-marketing Surveillance",
            "keywords": [
              "Pharmacovigilance",
              "Adverse Event Reporting System",
              "AERS",
              "Risk Evaluation and Mitigation Strategies",
              "REMS",
              "Signal Detection",
              "Real-World Evidence",
              "Safety Monitoring",
              "Post-Authorization Safety Studies",
              "PASS"
            ],
            "meshTerms": [
              "Pharmacovigilance[MeSH]",
              "Product Surveillance, Postmarketing[MeSH]",
              "Adverse Drug Reaction Reporting Systems[MeSH]"
            ],
            "textKeywords": [
              "Post-marketing[tiab]",
              "REMS[tiab]",
              "Real-World Evidence[tiab]",
              "Signal Detection[tiab]"
            ]
          }
        }
      }
    }
  }
}
